Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H22Cl2N2O |
| Molecular Weight | 329.265 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)[C@H]1CCCC[C@@H]1N(C)C(=O)C2=CC(Cl)=C(Cl)C=C2
InChI
InChIKey=JGPNMZWFVRQNGU-GJZGRUSLSA-N
InChI=1S/C16H22Cl2N2O/c1-19(2)14-6-4-5-7-15(14)20(3)16(21)11-8-9-12(17)13(18)10-11/h8-10,14-15H,4-7H2,1-3H3/t14-,15-/m0/s1
| Molecular Formula | C16H22Cl2N2O |
| Molecular Weight | 329.265 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:22:11 GMT 2025
by
admin
on
Tue Apr 01 16:22:11 GMT 2025
|
| Record UNII |
6IY4WX208T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-U-47700
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
||
|
DEA NO. |
9547
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U-47700
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
121348-98-9
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
82657-23-6
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
100000167006
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
6IY4WX208T
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
DTXSID601342914
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
18596
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY | |||
|
SUB181325
Created by
admin on Tue Apr 01 16:22:11 GMT 2025 , Edited by admin on Tue Apr 01 16:22:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
Emax 85.9 percent of Fentanyl
EC50
|
||
|
TARGET -> AGONIST |
BINDING
Ki
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->WEAK AGONIST |
EC50
|
||
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|